Luminex Revenue Climbs 49 Percent on Rising Assay, Technology Sales | GenomeWeb
NEW YORK (GenomeWeb news) – Luminex reported after the close of the market on Thursday that its third-quarter revenues jumped 49 percent as the firm swung from a loss to profitability.
 
The molecular diagnostics tools and assay developer brought in revenues of $28.9 million for the three-month period ended Sept. 30, compared to revenues of $19.4 million for the third quarter of 2007.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.